Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The United States Patent and Trademark Office (USPTO) has issued Patent No 7,776,845 to Harbor BioSciences for Triolex (HE3286).
Subscribe to our email newsletter
The patent covers compounds including Triolex and formulations that contain the drug or the other claimed compounds.
Harbor BioSciences said that Triolex is a compound for the treatment of responsive insulin resistant pre-diabetes and type 2 diabetes patients, operating by limiting inflammation in responsive patient populations.